Ulla Seppälä

652 citations
23 papers · 444 indexed · 1 hit paper · h-index 14

Impact in

    • Food Allergy and Anaphylaxis Research
    • Allergic Rhinitis and Sensitization
    • Contact Dermatitis and Allergies
    • Dermatology and Skin Diseases

Papers in

    • Allergic Rhinitis and Sensitization 12
    • Food Allergy and Anaphylaxis Research 12
    • Contact Dermatitis and Allergies 9
    • Dermatology and Skin Diseases 2

Ulla Seppälä

23 papers receiving 412 citations

Hit Papers

A phase 2a trial of the IL-33 monoclonal antibody tozorakimab in patients with COPD: FRONTIER-4 2025 · 19 citations
192025202651015

Peers

Ulla Seppälä
Comparison fields: 5 of 62
  • Immunology and Allergy 269
  • Dermatology 140
  • Insect Science 57
  • Biotechnology 28
  • Physiology 72
Replace R. Tinghino with:
R. Tinghino Italy
W.M. Becker Germany
Florentino Polo Spain
Jacqueline B. Nesbit United States
C. Ebner Austria
Joseph Stanley United States
Bárbara Cases Spain
Haruyo Okunuki Japan
K. Fötisch Germany
Hannes Oberkofler Austria
Ulla Seppälä relative to R. Tinghino Italy R. Tinghino's profile →
Citations per field
00.5×4.3×
R. Tinghino · 1×
Citations per year

Countries citing papers authored by Ulla Seppälä

Since Specialization
Citations

This map shows the geographic impact of Ulla Seppälä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulla Seppälä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulla Seppälä more than expected).

Fields of papers citing papers by Ulla Seppälä

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulla Seppälä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulla Seppälä. The network helps show where Ulla Seppälä may publish in the future.

Co-authors

The 25 scholars most cited alongside Ulla Seppälä, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ulla Seppälä Line = papers co-authored together Ulla Seppälä links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1 199965
2 200656
3 200043
4 200335
5 200134
6 200531
7 201128
8 200926
9 200423
10
A phase 2a trial of the IL-33 monoclonal antibody tozorakimab in patients with COPD: FRONTIER-4
Hit paper breakdown →
202519
11 201617
12 201317
13 200413
14 201113
15 200112
16 20054
17 20172
18 20241
19 20241
20 20001

About Ulla Seppälä

Ulla Seppälä is a scholar working on Immunology and Allergy, Dermatology, Physiology, Immunology and Emergency Medical Services, having authored 23 papers that have together received 444 indexed citations. Recurring topics across this work include Allergic Rhinitis and Sensitization (12 papers), Food Allergy and Anaphylaxis Research (12 papers), Contact Dermatitis and Allergies (9 papers), Pediatric health and respiratory diseases (5 papers), Asthma and respiratory diseases (5 papers), IL-33, ST2, and ILC Pathways (4 papers), Insect and Pesticide Research (2 papers) and Dermatology and Skin Diseases (2 papers). The work is most often cited by research in Immunology and Allergy (269 citations), Dermatology (140 citations), Insect Science (57 citations), Biotechnology (28 citations) and Physiology (72 citations). Ulla Seppälä has collaborated with scholars based in Denmark, United States and Finland. Frequent co-authors include Nisse Kalkkinen, K. Turjanmaa, Michael D. Spangfort, Timo Reunala, Timo Palosuo, T Palosuo, Harri Alenius, T. Reunala, Te Piao King and Rafaél I. Monsalve. Their work appears in journals such as Journal of Allergy and Clinical Immunology, Allergy, Immunology, Journal of Proteome Research and Pediatric Allergy and Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact